EDGAR Filing Documents for 0001193125-17-255963

Form 8-K - Current report:

SEC Accession No. 0001193125-17-255963

Filing Date

2017-08-11

Accepted

2017-08-11 16:20:58

Documents

Period of Report

2017-08-07

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	d439703d8k.htm	8-K	35994
2	EX-1.1	d439703dex11.htm	EX-1.1	213634
3	EX-4.1	d439703dex41.htm	EX-4.1	308647
4	EX-4.2	d439703dex42.htm	EX-4.2	478448
5	EX-5.1	d439703dex51.htm	EX-5.1	14857
6	EX-99.1	d439703dex991.htm	EX-99.1	8915
7	EX-99.2	d439703dex992.htm	EX-99.2	9430
8	GRAPHIC	g439703g0811064808989.jpg	GRAPHIC	2231
9	GRAPHIC	g439703g0811115353804.jpg	GRAPHIC	3954
10	GRAPHIC	g439703g0811115650485.jpg	GRAPHIC	3954
	Complete submission text file	0001193125-17-255963.txt		1085621

Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949

Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700

BIOMARIN PHARMACEUTICAL INC (Filer) CIK: 0001048477 (see all company filings)